Skip to main content

ALK

Stock
Industrials
Airlines

Performance overview

ALK Price
Price Chart

Forward-looking statistics

Beta
0.97
Risk
40.56%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Alaska Air Group Inc operates two airlines, Alaska and Horizon in three operating segments. The Mainline segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico, and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements (CPA). The Horizon segment includes the capacity sold to Alaska under a CPA. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary and Mileage Plan passenger revenue.

Company info

SectorIndustrials
IndustryAirlines
Employees18K
Market cap$5.2B

Fundamentals

Enterprise value$9.8B
Revenue$12.6B
Revenue per employee—
Profit margin2.86%
Debt to equity151.70

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$2.78
Dividend per share$4.50
Revenue per share$100.78
Avg trading volume (30 day)$144M
Avg trading volume (10 day)$137M
Put-call ratio—

Macro factor sensitivity

Growth+2.3
Credit+5.1
Liquidity-0.1
Inflation-3.1
Commodities-0.3
Interest Rates-1.6

Valuation

Dividend yield8.81%
PEG Ratio9.45
Price to sales0.49
P/E Ratio9.45
Enterprise Value to Revenue0.78
Price to book1.52

Upcoming events

Next earnings dayApril 24, 2025
Next dividend day—
Ex. dividend dayFebruary 14, 2020

News

Alaska Air Group (ALK) Suffers a Larger Drop Than the General Market: Key Insights

Alaska Air Group (ALK) reached $52.54 at the closing of the latest trading day, reflecting a -3.03% change compared to its last close.

Zacks Investment Research (July 11, 2025)
5 Biotech Stocks to Buy in 2025 Amid Uncertain Macroenvironment

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position EXEL, VRNA, ALKS, KNSA and IMCR well in this volatile sector.

Zacks Investment Research (July 2, 2025)
Boeing didn't train factory staff well enough in the lead up to the Alaska Airlines 737 Max blowout, NTSB says

The NTSB released a summary of their investigation into the Alaska Airlines door plug blowout in 2024. It cited Boeing's failure to "provide adequate training, guidance, and oversight" to its workers.

Business Insider (June 25, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free